- Home
- RLMD vs HRZN Comparison
RLMD vs HRZN Comparison
Compare RLMD & HRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- HRZN
- Stock Information
- Founded
- RLMD 2004
- HRZN 2008
- Country
- RLMD United States
- HRZN United States
- Employees
- RLMD N/A
- HRZN N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- HRZN Finance/Investors Services
- Sector
- RLMD Health Care
- HRZN Finance
- Exchange
- RLMD Nasdaq
- HRZN Nasdaq
- Market Cap
- RLMD 289.7M
- HRZN 275.7M
- IPO Year
- RLMD N/A
- HRZN 2010
- Fundamental
- Price
- RLMD $4.22
- HRZN $6.66
- Analyst Decision
- RLMD Buy
- HRZN Hold
- Analyst Count
- RLMD 2
- HRZN 4
- Target Price
- RLMD $5.50
- HRZN $7.44
- AVG Volume (30 Days)
- RLMD 2.1M
- HRZN 740.5K
- Earning Date
- RLMD 11-13-2025
- HRZN 10-28-2025
- Dividend Yield
- RLMD N/A
- HRZN 19.85%
- EPS Growth
- RLMD N/A
- HRZN N/A
- EPS
- RLMD N/A
- HRZN N/A
- Revenue
- RLMD N/A
- HRZN $98,899,000.00
- Revenue This Year
- RLMD N/A
- HRZN $0.85
- Revenue Next Year
- RLMD N/A
- HRZN $9.80
- P/E Ratio
- RLMD N/A
- HRZN N/A
- Revenue Growth
- RLMD N/A
- HRZN N/A
- 52 Week Low
- RLMD $0.24
- HRZN $5.71
- 52 Week High
- RLMD $5.12
- HRZN $9.99
- Technical
- Relative Strength Index (RSI)
- RLMD 72.46
- HRZN 56.19
- Support Level
- RLMD $3.81
- HRZN $6.35
- Resistance Level
- RLMD $5.12
- HRZN $6.60
- Average True Range (ATR)
- RLMD 0.55
- HRZN 0.15
- MACD
- RLMD 0.05
- HRZN -0.00
- Stochastic Oscillator
- RLMD 64.44
- HRZN 58.42
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About HRZN Horizon Technology Finance Corporation
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.